{"id":16480,"date":"2023-09-13T06:53:58","date_gmt":"2023-09-13T06:53:58","guid":{"rendered":"https:\/\/lawsuitlegit.com\/?p=16480"},"modified":"2023-09-20T03:04:02","modified_gmt":"2023-09-20T03:04:02","slug":"morbidity-study-of-former-marines-employees-and-dependents-potentially-exposed-to-contaminated-drinking-water-at-u-s-marine-corps-base-camp-lejeune","status":"publish","type":"post","link":"https:\/\/lawsuitlegit.com\/morbidity-study-of-former-marines-employees-and-dependents-potentially-exposed-to-contaminated-drinking-water-at-u-s-marine-corps-base-camp-lejeune\/","title":{"rendered":"Morbidity Study of Former Marines, Employees, and Dependents Potentially Exposed to Contaminated Drinking Water at U.S. Marine Corps Base Camp Lejeune"},"content":{"rendered":"

Morbidity Study of Former Marines, Employees, and Dependents Potentially Exposed to Contaminated Drinking Water at U.S. Marine Corps Base Camp Lejeune<\/p>\n

 <\/p>\n

April, 2018<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

Morbidity Study of Former Marines, Employees, and <\/strong><\/p>\n

Dependents Potentially Exposed to Contaminated Drinking <\/strong><\/p>\n

Water at U.S. Marine Corps Base Camp Lejeune <\/strong><\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0<\/strong><\/p>\n

 <\/p>\n

CONTENTS <\/strong><\/p>\n

EXECUTIVE SUMMARY......................................................................................................... 4 <\/a><\/p>\n

Introduction............................................................................................................................. 4 <\/a><\/p>\n

Methods................................................................................................................................... 4 <\/a><\/p>\n

Results and Conclusion........................................................................................................... 9 <\/a><\/p>\n

INTRODUCTION.................................................................................................................... 13 <\/a><\/p>\n

METHODS............................................................................................................................... 16 <\/a><\/p>\n

Study Hypotheses.................................................................................................................. 16 <\/a><\/p>\n

Study Population and Eligibility........................................................................................... 17 <\/a><\/p>\n

Data Collection...................................................................................................................... 18 <\/a><\/p>\n

Exposure Assessment............................................................................................................ 21 <\/a><\/p>\n

Data Analysis......................................................................................................................... 24 <\/a><\/p>\n

Analysis of disease risk in Marines.......................................................................................... 25 <\/a><\/p>\n

Analysis of disease risk in civilian employees......................................................................... 26 <\/a><\/p>\n

Sensitivity analyses................................................................................................................... 26 <\/a><\/p>\n

Interpretation of results............................................................................................................. 28 <\/a><\/p>\n

Presentation of results............................................................................................................... 30 <\/a><\/p>\n

RESULTS................................................................................................................................. 31 <\/a><\/p>\n

Cancer.................................................................................................................................... 33 <\/a><\/p>\n

Digestive organs.................................................................................................................... 33 <\/a><\/p>\n

Hematopoietic........................................................................................................................ 36 <\/a><\/p>\n

Respiratory............................................................................................................................ 38 <\/a><\/p>\n

Sex-specific........................................................................................................................... 39 <\/a><\/p>\n

Urinary................................................................................................................................... 41 <\/a><\/p>\n

Other...................................................................................................................................... 42 <\/a><\/p>\n

Non-cancer diseases.............................................................................................................. 44 <\/a><\/p>\n

Autoimmune diseases............................................................................................................ 44 <\/a><\/p>\n

Nervous system..................................................................................................................... 44 <\/a><\/p>\n

Reproductive organs.............................................................................................................. 46 <\/a><\/p>\n

Other...................................................................................................................................... 47 <\/a><\/p>\n

Sensitivity Analyses of Marines\/Navy and Civilian Employee Cohorts............................... 49 <\/a><\/p>\n

1999-2002 ATSDR Survey Cohort........................................................................................ 50 <\/a><\/p>\n

DISCUSSION........................................................................................................................... 51 <\/a><\/p>\n

LIMITATIONS......................................................................................................................... 54 <\/a><\/p>\n

CONCLUSIONS...................................................................................................................... 57 <\/a><\/p>\n

ACKNOWLEDGEMENT........................................................................................................ 58 <\/a><\/p>\n

REFERENCES......................................................................................................................... 59 <\/a><\/p>\n

TABLES.................................................................................................................................... 64 <\/a><\/p>\n

FIGURE 1............................................................................................................................... 105 <\/a><\/p>\n

APPENDIX.\u00a0 RESULTS OF SURVEYS SENT TO REGISTRANTS IN THE U.S. MARINE CORPS NOTIFICATION DATABASE................................................................................................................................................ 106 <\/a><\/p>\n

APPENDIX TABLES............................................................................................................. 115 <\/a><\/p>\n

 <\/p>\n

 <\/p>\n

\u00a0<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n